Past events

Discover cutting-edge strategies to tackle the urgent challenges facing the Pharmaceutical, MedTech, Animal Health, and Biotech industries. With new regulations, inflation, rising production costs, and evolving pricing models, this forum provides actionable insights to help you navigate and succeed in today’s complex landscape.

The World Orphan Drug Congress is the largest, most established European meeting dedicated to orphan drugs. From cell & gene therapy, genetic testing, market access to real world evidence, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create groundbreaking progress.

Our 90+ sessions are delivered by over 300 nationally recognized experts and offer attendees a broad range of perspectives and insights into health policy, practice management, oncology specialty pharmacy, and other pertinent topics

Achieving success in a pharma licensing negotiation process hinges on meticulous management of each step involved. Apart from knowing the theoretical framework, one must also gain significant practical expertise to ensure favourable outcomes. Learn from an industry expert and gain hands-on experience in realistic scenarios that accurately replicate the intricacies of the BioPharma sector.

To ensure you are ready to navigate your company/brands towards successful commercial launch in the US, a first step is to grasp the fundamental structure and dynamics of US market access. Secondly, you need to foresee the potential routes to successful market access and how to deal with the most common market access challenges. This course will give you all of that in just 1 day.

The AusBiotech conference has served as the leading international meeting place for the Australian life science community. Biotechnology continues to unlock vast potential for improving human life.

By attending this 2-day course you will get up the learning curve fast and know how to apply AI most effectively and efficiently in your Medical Affairs role. Not only will you have the opportunity to consult directly with a true AI-Medical Affairs expert, but you’ll also engage in meaningful discussions and share experiences with international peers, making this a truly unique learning experience.

This two-day congress aims to build meaningful collaborations within the industry, advocacy groups, clinicians, researchers and most importantly, patients and their caregivers.

Chairs and Co-chairs of the Member State Coordination Group on Health Technology Assessment (HTACG) and its subgroups will explain the process for joint clinical assessments (JCA) and joint scientific consultations (JSC). The webinar will also cover relevant guidance documents adopted by the HTACG.

This course offers a clear and practical introduction to statistical thinking tailored to the needs of Medical Affairs. You will learn the essential principles behind statistical analysis, develop the ability to critically assess the validity and relevance of study findings, and gain techniques to clearly communicate statistical results in a medical context.

This course is a must for brand/product managers and related pharma marketers early in their career because they need to quickly acquire the concepts and tools for generating successful brand marketing plans, as well as think and learn to act cross-functionally in today’s volatile, uncertain and complex environment. This course will also benefit more experienced brand managers and franchise leads who want to refresh their skills, as well as managers in medical affairs, market access and commercial functions who must contribute to agile and customer-centric brand planning processes.

By attending this 2-day course you will quickly get up the learning curve and know how to apply AI most effectively and efficiently in your pharma marketing role. You will not only have the chance to ask your specific questions to a true AI-Pharma Marketing expert, but also benefit from the unique opportunity to share experiences and engage in in-depth discussions with your international peers.

This 2-day workshop is designed for innovative marketing and sales staff who want to enhance customer-centricity through the selective adoption of digital in their communication with HCPs, patients, caregivers

The World Vaccine Congress Europe will bring together the most senior and informed industry experts across the entire vaccine landscape., covering vaccine progress in Infectious Diseases, Cancer Immunotherapy, One Health and Veterinary Vaccines, Clinical Development, Manufacture, Safety, Supply, Market Access and Emerging Infectious diseases

This course, led by two of Europe’s most respected forecasting experts in pharma, will teach you the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals.

Pharma/medtech products cannot be successful without a favourable cost-effectiveness and budget impact profile. Upon completion of this course, you will master the fundamentals of health economic evaluations as a non-health-economist, and add value to decisions and communications related to products in R&D and/or brands in the market.

Europe's Must-Attend Event for the Market Access Professionals in Pharma, Biotech and Lifescience. Pharma MARCON is the leading Market Access event for Pharma and Biotech in Europe bringing together 120+ senior MA and pricing professionals from across the pharma and biotech landscape for networking and exchange. Join us now and discuss the key industry topics and to create new partnerships

The goal of this course is to demystify market access for anyone involved. By participating, you will not only have the chance to ask your specific questions of a true expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers. Additionally, you will be equipped with clear schematic overviews of the market access systems in Europe’s major markets as a resource for reference in your daily work.

With 36 Sponsors and Exhibitors taking part in 2024 and over 230 pre-registered delegates from across the MedTech, Life Sciences and NHS sector, the Expo also incorporated a conference stream over the day with a mix of topics suited for the audience.

This conference will bring together stakeholders and policymakers to discuss the way forward following the UK’s Modern Industrial Strategy and what will be needed if its aims are to be achieved to reduce regulatory burdens and speed up innovation. Delegates will also examine the forthcoming Life Sciences Sector Plan, and plans for a streamlined and flexible regulatory framework with accelerated medicine approval processes, support for innovative therapies and increased alignment with international standards.